Moreover, only 2.8 percent of the semaglutide-treated participants, versus 4.1 percent of those who received placebo, reported levels of depression at some point during treatment that required evaluation by a mental health professional
NMR LipoProfile* that includes the LDL Cholesterol Particle Number, The Small LDL Particle Number, the LDL Size, as well as all the components of the standard Lipid Profile (Total Cholesterol, LDL, HDL and Triglycerides)
In clinical trials, it produced approximately twice the weight loss of older GLP-1 medications and other weight management drugs
Any of these could indicate you are receiving a lower effective dose than expected, whether from degradation or from other factors affecting tirzepatide effectiveness
Semaglutide helps regulate appetite and blood sugar levels by imitating the GLP-1 hormone